Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative Mass Spectrometry Characterizes Client Spectra of Components for Targeting of Membrane Proteins to and Their Insertion into the Membrane of the Human ER. | Int J Mol Sci | 2023 | 37762469 | PubTator, text mining | PubMed |
| The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target. | Int J Mol Sci | 2023 | 37762023 | PubTator, text mining | PubMed |
| Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation. | Brain Sci | 2023 | 37759937 | PubTator, text mining | PubMed |
| The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets. | Brain Sci | 2023 | 37759870 | PubTator, text mining | PubMed |
| Linking Adiposity to Interstitial Lung Disease: The Role of the Dysfunctional Adipocyte and Inflammation. | Cells | 2023 | 37759429 | PubTator, text mining | PubMed |
| Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases. | Exp Neurobiol | 2023 | 37749925 | PubTator, text mining | PubMed |
| Loss of HES1 expression is associated with extracellular matrix remodeling and tumor immune suppression in KRAS mutant colon adenocarcinomas. | Sci Rep | 2023 | 37749297 | PubTator, text mining | PubMed |
| Unveiling novel insights in prostate cancer through single-cell RNA sequencing. | Front Oncol | 2023 | 37746302 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy. | Front Immunol | 2023 | 37731504 | PubTator, text mining | PubMed |
| NKX3.1 Expression Contributes to Epithelial-Mesenchymal Transition of Prostate Cancer Cells. | ACS Omega | 2023 | 37720744 | PubTator, text mining | PubMed |
| Correlation of tumor-associated macrophage infiltration in glioblastoma with magnetic resonance imaging characteristics: a retrospective cross-sectional study. | Quant Imaging Med Surg | 2023 | 37711787 | PubTator, text mining | PubMed |
| Major vault protein (MVP) suppresses aging- and estrogen deficiency-related bone loss through Fas-mediated apoptosis in osteoclasts. | Cell Death Dis | 2023 | 37704623 | PubTator, text mining | PubMed |
| Interactions between microglia and glioma in tumor microenvironment. | Front Oncol | 2023 | 37700840 | PubTator, text mining | PubMed |
| SPP1/osteopontin: a driver of fibrosis and inflammation in degenerative ascending aortic aneurysm? | J Mol Med (Berl) | 2023 | 37698712 | PubTator, text mining | PubMed |
| Development of an in vitro genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants. | Mol Ther Methods Clin Dev | 2023 | 37693949 | PubTator, text mining | PubMed |
| The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro. | Cancers (Basel) | 2023 | 37686550 | PubTator, text mining | PubMed |
| Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways. | Cells | 2023 | 37681924 | PubTator, text mining | PubMed |
| PGC-1α inhibits M2 macrophage polarization and alleviates liver fibrosis following hepatic ischemia reperfusion injury. | Cell Death Discov | 2023 | 37679346 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. | Front Immunol | 2023 | 37675100 | PubTator, text mining | PubMed |
| Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer. | Front Immunol | 2023 | 37671167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=18